{
  "id": "SCR-LIP-000770",
  "statement": "Lipo-lymphedema is frequently described as an advanced stage or complication of lipedema attributed to chronic lymphatic overload, though cohort evidence of conversion is lacking.",
  "claim_type": "clinical_association",
  "context": {
    "population": "patients with advanced lipedema",
    "condition": "lipedema",
    "exposure": "advanced/chronic lipedema",
    "comparator": "early-stage lipedema",
    "outcome": "secondary lymphedema (lipolymphedema) / lymph stasis",
    "scope": "disease progression (consensus)"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.1590/1677-5449.202301832",
      "stance": "supporting",
      "study_design": "consensus",
      "n": 113,
      "risk_of_bias": "moderate",
      "year": 2025,
      "amato_authored": true,
      "note": "consensus: lipolymphedema as a complication 3.95 (level B); lymph stasis more evident in advanced stages 4.36",
      "title": "Brazilian Consensus Statement on Lipedema using the Delphi methodology",
      "authors": "Amato et al.",
      "journal": "Jornal Vascular Brasileiro",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The abstract explicitly mentions 'lipolinfedema' (lipolymphedema) as one of the topics discussed in the consensus, and the context of advanced lipedema progressing to lymphatic complications is consistent with the consensus content. The sta",
        "date": "2026-06-10"
      },
      "quote": "9 afirmações não atingiram o limiar de suficiência de evidência (critério 4), sinalizando lacunas científicas explícitas: microvasculatura, lipolinfedema",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Delphi consensus agreed lipolymphedema is a complication (3.95, level B) and lymph stasis is more evident in advanced stages (4.36), while flagging lipolymphedema as an evidence gap.",
      "from_claims": [
        "SCR-LIP-000018"
      ]
    },
    {
      "ref": "DOI:10.1002/oby.23458",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2022,
      "amato_authored": false,
      "note": "Pilot study with 20 participants addressing lymphatic anatomy and function in early lipedema; directly relevant to the question of progression to lymphedema and functional disability, but refines rather than simply supports or contradicts b",
      "title": "Lymphatic function and anatomy in early stages of lipedema",
      "authors": "Rasmussen et al.",
      "journal": "Obesity",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article directly supports all elements of the statement: dilated lymphatic vessels, increased propulsion rates, absence of dermal backflow in Stage I-II lipedema, and the conclusion tha",
        "date": "2026-06-10"
      },
      "quote": "The lymphatic failure is NOT involved in the etiology of early lipedema, although it likely contributes to progression to lipolymphedema.",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "refines",
      "finding": "NIRF imaging in early-stage lipedema: dilated vessels and increased propulsion without dermal backflow; lymphatic failure absent in early disease but likely contributes to progression to lipolymphedema.",
      "from_claims": [
        "SCR-LIP-000124"
      ]
    },
    {
      "title": "Lymphoscintigraphic Findings in Patients With Lipedema: A Systematic Review.",
      "authors": "Mortada H, Alsaif MA, AlJohani A, Altuwaijri AM, Alshomer F.",
      "ref": "DOI:10.1097/gox.0000000000008015",
      "stance": "refines",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "moderate",
      "year": 2026,
      "amato_authored": false,
      "quote": "Lymphoscintigraphy findings were normal in 61.4% of patients with lipedema. Tortuous lymph vessels were the most common abnormality (56.8%), followed by collateral lymph vessels (49.1%) and popliteal node visualization (44.0%). Dermal backflow (3.8%) and secondary lymphedema (11.8%) were less freque",
      "extraction_confidence": "high",
      "note": "The review reports lymphoscintigraphy patterns in lipedema (mostly normal or overload signs, low dermal backflow) that help distinguish it from lymphedema, but stresses methodological heterogeneity and lack of standardized protocols, qualif",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "All specific numbers (7 studies, 470 patients, 311 with lipedema, 61.4% normal, 56.8% tortuous, 49.1% collateral, 44.0% popliteal, 3.8% dermal backflow) and the conclusion about lymphatic overload rather than frank insufficiency are directl",
        "date": "2026-08-23"
      },
      "stance_in_source_claim": "refines",
      "finding": "Systematic review (311 lipedema patients): lymphoscintigraphy normal in 61.4%; secondary lymphedema in 11.8% and dermal backflow in 3.8%, pattern read as overload rather than insufficiency.",
      "from_claims": [
        "SCR-LIP-000429"
      ]
    },
    {
      "ref": "DOI:10.14740/jmc3806",
      "stance": "supporting",
      "study_design": "case_report",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2022,
      "amato_authored": false,
      "note": "Single case report describing co-occurrence and progression of lipedema with lymphedema and obesity as aggravating factor; it documents overlap and progression rather than directly testing whether lipedema is a distinct disease entity, so i",
      "title": "Lipedema in Male Progressing to Subclinical and Clinical Systemic Lymphedema",
      "authors": "Pereira de Godoy et al.",
      "journal": "Journal of Medical Cases",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article is a case report of a 53-year-old male with lipedema co-occurring with post-surgical lymphedema, progressing to systemic lymphedema over 3 years as detected by multi-segment bioimpedance. The 50% figure for lymphedema detection ",
        "date": "2026-06-10"
      },
      "quote": "The physical examination revealed lipedema and lymphedema in the right lower limb.",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "context",
      "finding": "Case report of a man with lipedema and post-surgical limb lymphedema: over 3 years, progression from subclinical to clinical systemic lymphedema by bioimpedance.",
      "from_claims": [
        "SCR-LIP-000261"
      ]
    },
    {
      "title": "Lipedema and Lymphatic Edema",
      "ref": "DOI:10.1007/3-540-28043-x_3",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2006,
      "amato_authored": false,
      "quote": "Em estágios avançados, o lipedema pode obstruir vasos linfáticos e causar linfedema secundário (lipo-linfedema) — progressão bem documentada pela linfocintilografia",
      "extraction_confidence": "high",
      "note": "Narrative review states that advanced lipedema can progress to secondary lymphedema (lipo-lymphedema), a well-recognized complication, supporting the progression component of the question; functional disability is not directly quantified.",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article abstract explicitly states that advanced lipedema can obstruct lymphatic vessels causing secondary lymphedema (lipo-lymphedema) documented by lymphoscintigraphy, and mentions lymphatic capillary microaneurysms (Amann-Vesti 2001)",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "supporting",
      "finding": "Review states advanced lipedema can obstruct lymphatics and cause secondary lymphedema documented by lymphoscintigraphy, with lymphatic microaneurysms seen even early.",
      "from_claims": [
        "SCR-LIP-000494"
      ]
    },
    {
      "ref": "DOI:10.1097/psn.0000000000000245",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2018,
      "amato_authored": false,
      "note": "This is a narrative/educational review article summarizing existing literature on lipedema. It directly addresses progression to lymphedema (lipolymphedema, Stage IV) and functional disability (immobility, decreased quality of life), suppor",
      "title": "Lipedema: A Commonly Misdiagnosed Fat Disorder",
      "authors": "Caruana",
      "journal": "Plastic Surgical Nursing",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly states lipedema is progressive and can lead to immobility and significant decrease in quality of life, and describes Stage IV as lipolymphedema with dorsal foot edema and positive Stemmer sign — all consistent with th",
        "date": "2026-06-10"
      },
      "quote": "Early diagnosis and treatment are crucial, as the disease is progressive and can lead to immobility as well as a significant decrease in the qualit",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review describes lipedema as progressive, advancing to stage IV lipolymphedema with dorsal foot edema and positive Stemmer sign, leading to immobility.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    },
    {
      "ref": "DOI:10.1002/oby.22597",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2019,
      "amato_authored": false,
      "note": "Narrative/systematic review describing lipedema staging where stage IV is lipolymphedema (positive Stemmer), consistent with progression to lymphedema and deforming morphology affecting function, but it does not present quantitative data on",
      "title": "Lipedema: A Call to Action!",
      "authors": "Buso et al.",
      "journal": "Obesity",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly describes Stage IV as 'lipolinfedema com Stemmer positivo' and characterizes lipedema as a chronic progressive disease leading to disability and daily functioning impairment, consistent with the statement. The staging",
        "date": "2026-06-10"
      },
      "quote": "4 estágios (I: pele lisa, hipodermis aumentada; II: nódulos palpáveis peau d'orange; III: pregas/reentrâncias com massas deformantes; IV: lipolinfedema com Stemmer positivo)",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Review describes four stages, stage IV being lipolymphedema with positive Stemmer sign.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    },
    {
      "ref": "DOI:10.3390/biomedicines10123081",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2022,
      "amato_authored": false,
      "note": "The review explicitly outlines a progressive staging system ending in lipolymphedema (stage 4) and associates lipedema with chronic pain and functional/discomfort symptoms, supporting the affirmative direction; however, it is a narrative sy",
      "title": "Lipedema: Insights into Morphology, Pathophysiology, and Challenges",
      "authors": "Poojari et al.",
      "journal": "Biomedicines",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly describes four progressive stages with stage 4 as lipolymphedema, documents lymphovascular dysfunction (decreased PROX-1, increased VEGFR-3/VEGF-C, endothelial permeability via CDH5/VE-cadherin and ZO-1 reduction), no",
        "date": "2026-06-10"
      },
      "quote": "Quatro estágios progressivos (E1 nódulos perolados; E2 depressões + fascia perilobular contraída; E3 lobos deformantes + perda de elasticidade; E4 lipolinfedema)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review describes four progressive stages culminating in stage 4 lipolymphedema, noting it is unclear whether lymphatic dysfunction is cause or consequence.",
      "from_claims": [
        "SCR-LIP-000333"
      ]
    },
    {
      "ref": "DOI:10.1111/ijd.70227",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "note": "The review characterizes lipedema as progressive with impaired mobility and quality of life impact, supporting functional disability; it distinguishes lipedema from lymphedema but does not quantify progression to lymphedema, relying on obse",
      "title": "Lipedema Diagnosis, Clinical Manifestations, and Therapeutics: A Systematic Review",
      "authors": "Vazirnia et al.",
      "journal": "International Journal of Dermatology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The abstract describes lipedema as a 'chronic,' 'progressive condition' associated with 'impaired mobility' and implicitly with lymphedema overlap (noting misdiagnosis as lymphedema). The statement's additional specifics (Stage IV, dorsal f",
        "date": "2026-06-10"
      },
      "quote": "Lipedema is a distinct, progressive condition requiring early recognition and intervention.",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Systematic review characterizes lipedema as a distinct, progressive condition requiring early recognition, without quantifying progression to lymphedema.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    },
    {
      "ref": "DOI:10.1089/lrb.2021.0039",
      "stance": "context",
      "study_design": "case_series",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2021,
      "amato_authored": false,
      "note": "Small (n=5) uncontrolled proof-of-principle therapy study; it enrolled patients with lipedema plus early lymphedema and addressed functional mobility, providing contextual evidence that lipedema can coexist with lymphedema and impair functi",
      "title": "Physical Therapy in Women with Early Stage Lipedema: Potential Impact of Multimodal Manual Therapy, Compression, Exercise, and Education Interventions",
      "authors": "Donahue et al.",
      "journal": "Lymphatic Research and Biology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article confirms n=5 women with Stage 1-2 lipedema and early Stage 0-1 lymphedema, VAS reduction from 4.6±1.8 to 0.0±0.0, and PSFS improvement from 4.5±0.5 to 8.3±1.0, all matching the statement. The enrollment criteria do indicate coex",
        "date": "2026-06-10"
      },
      "quote": "Participants with Stage 1-2 lipedema and early Stage 0-1 lymphedema (n = 5, age = 38.4 ± 13.4 years, body mass index = 27.2 ± 4.3 kg/m2) underwent nine visits of physical therapy in 6 weeks for management of symptoms impacting functional mobility and QoL.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "Five women with early lipedema had concurrent early-stage lymphedema at enrolment in a physical therapy study (pain VAS 4.6 to 0.0 after therapy).",
      "from_claims": [
        "SCR-LIP-000336"
      ]
    },
    {
      "ref": "DOI:10.1097/00006534-199411000-00014",
      "stance": "context",
      "study_design": "case_series",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 1994,
      "amato_authored": false,
      "note": "The article argues that lipedema is distinct from lymphedema and does not progress to it, contradicting the premise that lipedema progresses to lymphedema. However, it is a small retrospective case series (n=9) and does not directly study l",
      "title": "Lipedema",
      "authors": "Rudkin & Miller",
      "journal": "Plastic and Reconstructive Surgery",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article directly supports all key claims in the statement: 250 lymphedema cases reviewed, 9 patients identified with lipedema, bilateral symmetric swelling sparing the feet, absent lymphedema skin changes (including Stemmer sign), fat p",
        "date": "2026-06-10"
      },
      "quote": "These findings are representative of a clinical entity known as lipedema, which is distinct from lymphedema and for which treatment may be different.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Among 250 lymphedema referrals, 9 lipedema patients showed symmetric foot-sparing swelling and negative Stemmer sign, framed as an entity distinct from lymphedema.",
      "from_claims": [
        "SCR-LIP-000128"
      ]
    },
    {
      "title": "Dicker durch Fett oder Wasser — Lipohyperplasia dolorosa vs. Lymphödem",
      "ref": "DOI:10.1007/s00105-010-1987-7",
      "stance": "contradicting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2010,
      "amato_authored": false,
      "quote": "Lipohyperplasia dolorosa and lymphedema are completely different disease entities, which are both, however, classified under lymphology.",
      "extraction_confidence": "moderate",
      "note": "The article explicitly frames lipedema and lymphedema as completely different entities with distinct etiologies, which argues against the premise that lipedema progresses into lymphedema; it does not report longitudinal progression or funct",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "contradicting",
        "verdict": "verified",
        "reason": "The article explicitly states lipohyperplasia dolorosa and lymphedema are 'completely different disease entities,' with lipedema being a congenital fat distribution disorder, not a precursor to lymphedema. The statement accurately reflects ",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "contradicting",
      "finding": "Review frames lipohyperplasia dolorosa and lymphedema as completely different disease entities, lipedema being a fat distribution disorder rather than a precursor of lymphedema.",
      "from_claims": [
        "SCR-LIP-000495"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [
    {
      "name": "Alexandre C. M. Amato",
      "orcid": "0000-0003-4008-4029",
      "role": "lead_curator"
    }
  ],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000018",
    "SCR-LIP-000124",
    "SCR-LIP-000429",
    "SCR-LIP-000261",
    "SCR-LIP-000494",
    "SCR-LIP-000129",
    "SCR-LIP-000333",
    "SCR-LIP-000336",
    "SCR-LIP-000128",
    "SCR-LIP-000495"
  ],
  "questions_consolidated": [
    "SQ-LIP-000039"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00216",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round + arbitration)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000039"
    }
  ],
  "statement_pt": "O lipolinfedema é frequentemente descrito como um estágio avançado ou uma complicação do lipedema atribuída à sobrecarga linfática crônica, embora faltem evidências de coortes sobre a conversão.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000039",
      "role": "supporting",
      "question": "Does lipedema progress to lymphedema (lipo-lymphedema)?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000039.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000770.html"
}